Sign Up to like & get
recommendations!
0
Published in 2017 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.23712
Abstract: The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) potentiator ivacaftor (Kalydeco®) improves clinical outcome in G551D cystic fibrosis (CF) patients. Here, we have investigated whether ivacaftor has a clinical impact on non‐G551D gating mutations and function…
read more here.
Keywords:
ivacaftor;
cystic fibrosis;
fibrosis;
cftr dependent ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Science Advances"
DOI: 10.1126/sciadv.adg5128
Abstract: An intense, nonresolving airway inflammatory response leads to destructive lung disease in cystic fibrosis (CF). Dysregulation of macrophage immune function may be a key facet governing the progression of CF lung disease, but the underlying…
read more here.
Keywords:
ifn signaling;
type ifn;
dysregulation;
cftr dependent ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "JCI Insight"
DOI: 10.1172/jci.insight.159832
Abstract: Chronic type 2 (T2) inflammatory diseases of the respiratory tract are characterized by mucus overproduction and disordered mucociliary function, which are largely attributed to the effects of IL-13 on common epithelial cell types (mucus secretory…
read more here.
Keywords:
airway tuft;
mucociliary function;
tuft cells;
cftr dependent ... See more keywords